Patents Review shows SARS-CoV-2 is no novel Virus
Dr. David Martin, CEO of M-CAM International (risk management) has reviewed 4,000 Coronavirus patents.
He appeared on Sitting #60 of the German Corona Committee on July 9 2021 to share his findings in a 90 minute discussion with lawyers of the Ausschuss and Dr. Wolfgang Wodarg, Germany's most experienced lung doctor. His clear and verifiable conclusion is that there is nothing at all novel about the SARS-CoV-2 gene sequence used as a basis for the Covid vaccines.
Further from a patent standpoint, there seems to be no way of knowing what exact sequence is being used in the vaccines and therefore what people are being injected with. Drs Martin & Fuellmich consider this situation to be a RICO (Racketeer Influenced and Corrupt Organizations Act) legal case.
➥ This way to the video
➥ This way to a short extract
Lawyer Dr. Reiner Fuellmich, go to channel here:
@ReinerFuellmichEnglish
